Coronary artery disease in patients with cystic fibrosis – A case series and review of the literature

Progressive obstructive pulmonary disease is the primary life-shortening complication in people with Cystic Fibrosis (CF); improvement in life expectancy has led to increased prevalence of non-pulmonary complications. Patients with CF are considered to be at low risk for coronary artery disease (CAD...

Full description

Bibliographic Details
Main Authors: Zahrae Sandouk, Noura Nachawi, Richard Simon, Jennifer Wyckoff, Melissa S. Putman, Sarah Kiel, Sarah Soltman, Antoinette Moran, Amir Moheet
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Journal of Clinical & Translational Endocrinology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214623722000163
_version_ 1811201991441907712
author Zahrae Sandouk
Noura Nachawi
Richard Simon
Jennifer Wyckoff
Melissa S. Putman
Sarah Kiel
Sarah Soltman
Antoinette Moran
Amir Moheet
author_facet Zahrae Sandouk
Noura Nachawi
Richard Simon
Jennifer Wyckoff
Melissa S. Putman
Sarah Kiel
Sarah Soltman
Antoinette Moran
Amir Moheet
author_sort Zahrae Sandouk
collection DOAJ
description Progressive obstructive pulmonary disease is the primary life-shortening complication in people with Cystic Fibrosis (CF); improvement in life expectancy has led to increased prevalence of non-pulmonary complications. Patients with CF are considered to be at low risk for coronary artery disease (CAD). We report here a case series of six patients with CF with and without known cystic fibrosis related diabetes (CFRD) who had acute myocardial infarction (AMI) requiring coronary stent placement. This was a heterogeneous group of patients, without a clear pattern of consistent risk factors. Interestingly, most patients in this cohort had low LDL. In this review, we discuss risk factors of cardiovascular disease (CVD) that may apply to the CF population. While CAD is rare in people with CF, it does occur. We postulate that the risk will grow with increased longevity and the increased prevalence of co-morbidities such as obesity and dyslipidemia.
first_indexed 2024-04-12T02:31:13Z
format Article
id doaj.art-ad86e030370749dd8e7341a0a9dba094
institution Directory Open Access Journal
issn 2214-6237
language English
last_indexed 2024-04-12T02:31:13Z
publishDate 2022-12-01
publisher Elsevier
record_format Article
series Journal of Clinical & Translational Endocrinology
spelling doaj.art-ad86e030370749dd8e7341a0a9dba0942022-12-22T03:51:45ZengElsevierJournal of Clinical & Translational Endocrinology2214-62372022-12-0130100308Coronary artery disease in patients with cystic fibrosis – A case series and review of the literatureZahrae Sandouk0Noura Nachawi1Richard Simon2Jennifer Wyckoff3Melissa S. Putman4Sarah Kiel5Sarah Soltman6Antoinette Moran7Amir Moheet8Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, MI, USA; Corresponding author at: MEND Division, University of Michigan, Lobby C. 24 Frank Lloyd Wright Drive, Ann Arbor, MI 48105, USA.Division of Endocrinology, Cleveland Clinic, Cleveland, OH, USADivision of Pulmonology, University of Michigan, Ann Arbor, MI, USADivision of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, MI, USADivisions of Endocrinology, Massachusetts General Hospital and Boston Children’s Hospital, MA, USADivision of Pulmonary, Allergy, and Critical Care Medicine, University of Minnesota. Minneapolis, MN, USADivision of Endocrinology, Oregon Health and Sciences University, Portland, OR, USADepartment of Pediatrics, University of Minnesota, Minneapolis, MN, USADepartment of Medicine, University of Minnesota, Minneapolis, MN, USAProgressive obstructive pulmonary disease is the primary life-shortening complication in people with Cystic Fibrosis (CF); improvement in life expectancy has led to increased prevalence of non-pulmonary complications. Patients with CF are considered to be at low risk for coronary artery disease (CAD). We report here a case series of six patients with CF with and without known cystic fibrosis related diabetes (CFRD) who had acute myocardial infarction (AMI) requiring coronary stent placement. This was a heterogeneous group of patients, without a clear pattern of consistent risk factors. Interestingly, most patients in this cohort had low LDL. In this review, we discuss risk factors of cardiovascular disease (CVD) that may apply to the CF population. While CAD is rare in people with CF, it does occur. We postulate that the risk will grow with increased longevity and the increased prevalence of co-morbidities such as obesity and dyslipidemia.http://www.sciencedirect.com/science/article/pii/S2214623722000163Cystic fibrosisCystic fibrosis related diabetesCoronary artery diseaseHyperlipidemiaLow cholesterol levelRisk factors
spellingShingle Zahrae Sandouk
Noura Nachawi
Richard Simon
Jennifer Wyckoff
Melissa S. Putman
Sarah Kiel
Sarah Soltman
Antoinette Moran
Amir Moheet
Coronary artery disease in patients with cystic fibrosis – A case series and review of the literature
Journal of Clinical & Translational Endocrinology
Cystic fibrosis
Cystic fibrosis related diabetes
Coronary artery disease
Hyperlipidemia
Low cholesterol level
Risk factors
title Coronary artery disease in patients with cystic fibrosis – A case series and review of the literature
title_full Coronary artery disease in patients with cystic fibrosis – A case series and review of the literature
title_fullStr Coronary artery disease in patients with cystic fibrosis – A case series and review of the literature
title_full_unstemmed Coronary artery disease in patients with cystic fibrosis – A case series and review of the literature
title_short Coronary artery disease in patients with cystic fibrosis – A case series and review of the literature
title_sort coronary artery disease in patients with cystic fibrosis a case series and review of the literature
topic Cystic fibrosis
Cystic fibrosis related diabetes
Coronary artery disease
Hyperlipidemia
Low cholesterol level
Risk factors
url http://www.sciencedirect.com/science/article/pii/S2214623722000163
work_keys_str_mv AT zahraesandouk coronaryarterydiseaseinpatientswithcysticfibrosisacaseseriesandreviewoftheliterature
AT nouranachawi coronaryarterydiseaseinpatientswithcysticfibrosisacaseseriesandreviewoftheliterature
AT richardsimon coronaryarterydiseaseinpatientswithcysticfibrosisacaseseriesandreviewoftheliterature
AT jenniferwyckoff coronaryarterydiseaseinpatientswithcysticfibrosisacaseseriesandreviewoftheliterature
AT melissasputman coronaryarterydiseaseinpatientswithcysticfibrosisacaseseriesandreviewoftheliterature
AT sarahkiel coronaryarterydiseaseinpatientswithcysticfibrosisacaseseriesandreviewoftheliterature
AT sarahsoltman coronaryarterydiseaseinpatientswithcysticfibrosisacaseseriesandreviewoftheliterature
AT antoinettemoran coronaryarterydiseaseinpatientswithcysticfibrosisacaseseriesandreviewoftheliterature
AT amirmoheet coronaryarterydiseaseinpatientswithcysticfibrosisacaseseriesandreviewoftheliterature